Binding of Rasagiline-Related Inhibitors to Human Monoamine Oxidases: A Kinetic and Crystallographic Analysis.
Binda, C., Hubalek, F., Li, M., Herzig, Y., Sterling, J., Edmondson, D.E., Mattevi, A.(2005) J Med Chem 48: 8148
- PubMed: 16366596 
- DOI: 10.1021/jm0506266
- Primary Citation of Related Structures:  
2C64, 2C65, 2C66, 2C67 - PubMed Abstract: 
Monoamine oxidases A and B (MAO A and B) catalyze the degradation of neurotransmitters and represent drug targets for the treatment of neurodegenerative disorders. Rasagiline is an irreversible, MAO B-selective inhibitor that has been approved as a novel anti-Parkinson's drug ...